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between benign a d malignant adrenal masses. Burr and 
coworkers in fact refer to our 1992 article and acknowl- 
edge that chemical-shift MRI might be more effective 
than the methods they used. They did not, as they state, 
use the "best currently available MRI scanning tech- 
niques" for their 1994 publication. 
I hope that Burt and associates and other thoracic and 
cardiovascular surgeons maintain their interest in the 
potential impact of MRI on presurgical diagnosis. Well- 
designed studies on this subject would be of benefit o the 
surgical and radiologic literature alike. 
Donald G. Mitchell, MD 
Professor of Radiology 
Thomas Jefferson University Hospital 
Jefferson Medical College 
132 South lOth St. 
196 Main Building 
Philadelphia, PA 19107 
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Reply to the Editor: 
In response to Dr. Donald G. Mitchell's letter to the 
Editor, we have the following comments. We thank Dr. 
Mitchell for his comments and criticisms. Although mag- 
netic resonance imaging (MRI) methods are currently 
being investigated that possibly could lead to better 
discrimination of adrenal masses as being benign or 
metastatic n non-small-cell lung cancer, Dr. Mitchell did 
not take into account the time it takes for a scientific study 
to come to full publication. The inception of the study was 
in February of 1990, and it was approved by our institu- 
tional review board in April of 1990. The accrual of the 
patients reported in our study began in August of 1990 
and was completed in October of 1992. An abstract of our 
study was submitted to The American Association for 
Thoracic Surgery on November 11, 1993, and the paper 
was presented at the Seventy-third Annual Meeting in 
April of 1993. A manuscript was submitted at this meet- 
ing. This manuscript was accepted August 20, 1993, and 
published in the February 1994 issue of THE JOUm~AL Or 
THORACIC AND CARDIOVASCULAR SURGERY. Dr. Mitchell 
published his technique of chemical shift MRI in the 
November 1992 issue of Radiology, after the completion of 
our study. 
Although newer techniques are being developed in 
MRI to differentiate benign from malignant adrenal 
masses, few studies have histologic documentation f all 
patients reported. Therefore, although our study used the 
MRI techniques available during the period of the study, 
the point is still valid that the gold standard for determin- 
ing the cause of adrenal masses is by cytopathologic or
histopathologic study. We too are currently evaluating 
chemical-shift MRI and other newer MRI techniques, but 
we remain convinced that histologic examination is the 
gold standard by which to compare any new MRI tech- 
nique. 
Michael Burt, MD, PhD a 
Robert Heelan, MD b 
Department of Surgery a 
Department of Radiology b 
Memorial Sloan-Kettering Cancer Center 
1275 York Ave. 
New York, NY 10021 
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Airway complications after lung transplantation: 
Is there a left-sided predilection? 
To the Editor: 
We read with interest he article by Griffith and asso- 
ciates 1 that was published in this JOURNAL. They have 
clearly shown that most complications of airway anasto- 
moses after lung transplantation can be avoided by the 
refinement of surgical techniques (Table I, J THOgAC 
CARDIOVASC SURG 1994;107:746). Although the etiology 
of impaired bronchial healing after lung transplantation is 
multifactorial, bronchial ischemia seems to be the primary 
cause. 2 In this series all seven patients with severe bron- 
chial stenoses after bilateral lung transplantation had 
stenotic lesions of the left bronchus (three had bilateral 
stenoses). These patients were treated with endobronchial 
stents. Two patients had bronchial stenosis necessitating 
stenting after single left lung transplantations; by contrast, 
no bronchial stenoses occurred after single right lung 
transplantation (Table II, J THORAC CARDIOVASC SUR~ 
1994;107:746). Colt and associates 3 also have reported 
that all ten patients in whom stenosis developed after 
double lung transplantation demonstrated abnormalities 
at the level of the left main bronchial anastomosis (three 
had bilateral stenoses). 
